NZSE:RYMHealthcare
A Look at Ryman Healthcare (NZSE:RYM) Valuation Following Better-Than-Expected FY26 Sales Volumes
Ryman Healthcare (NZSE:RYM) revealed that its current volumes are outpacing FY26 expectations, with second quarter sales for FY26 up 9% quarter on quarter. This operational momentum appears to be sparking renewed attention from the market.
See our latest analysis for Ryman Healthcare.
After a tough stretch for shareholders, Ryman Healthcare’s upbeat sales outlook and the recent bounce have started shifting sentiment. While the 90-day share price return stands at a strong 16.4%, the total...